Belviq lawsuits allege weight loss drug linked to increased cancer risk

The manufacturers of the weight loss drug Belviq (lorcaserin) — Eisai Inc. and Arena Pharmaceuticals — are facing several lawsuits over allegations that the medication is linked to an increased cancer risk. Patients who used Belviq to lose weight and have been diagnosed with cancer may qualify to take legal action and receive compensation for their injuries. (more…)

By |2020-10-19T16:49:19+00:00August 26th, 2020|Belviq|Comments Off on Belviq lawsuits allege weight loss drug linked to increased cancer risk

J&J, Janssen face class action lawsuit over permanent eye damage caused by Elmiron

A Nevada woman who suffered permanent retinal damage in both eyes after using the bladder drug Elmiron filed a class action lawsuit against the makersof the drug in Pennsylvania. Tina Pisco’s class action against Johnson & Johnson and Janssen Pharmaceuticals alleges that the drugmakers knew the risk of eye damage associated with Elmiron, but failed to properly warn doctors and patients. (more…)

By |2020-10-22T14:49:51+00:00August 24th, 2020|Elmiron|Comments Off on J&J, Janssen face class action lawsuit over permanent eye damage caused by Elmiron

Elmiron may cause serious eye damage, study finds

Recent studies have shown that patients treated with the drug Elmiron over an extended period are at risk of developing retinal damage, vision loss, and even blindness. According to one study, 25% of patients treated with Elmiron for five years or more developed vision problems as a result of taking the drug. (more…)

By |2020-10-19T16:48:43+00:00July 28th, 2020|Elmiron|Comments Off on Elmiron may cause serious eye damage, study finds

Court upholds verdict that Roundup caused California groundskeeper’s lymphoma cancer

The California Court of Appeals upheld a multimillion-dollar verdict against Bayer and Monsanto over the link between the weedkiller Roundup and lymphoma. The court agreed with a jury verdict that former groundskeeper Dwayne “Lee” Johnson developed non-Hodgkin lymphoma from years of exposure to Roundup. The court reduced the original damages award in the case to $20.5 million. (more…)

By |2020-10-22T14:52:57+00:00July 22nd, 2020|Roundup & Glyphosate|Comments Off on Court upholds verdict that Roundup caused California groundskeeper’s lymphoma cancer

Proposed $10 billion Roundup lawsuits settlement announced by Bayer

Bayer recently announced that it will pay more than $10 billion to settle thousands of lawsuits involving the weedkiller Roundup. However, the process of finalizing the settlement is currently on hold, as the judge overseeing the Roundup lawsuits has indicated that he may reject a portion of the settlement. (more…)

By |2020-10-19T16:41:49+00:00July 8th, 2020|Roundup & Glyphosate|Comments Off on Proposed $10 billion Roundup lawsuits settlement announced by Bayer

What is the difference between mesothelioma lawsuits and asbestos trust fund claims?

For decades, the use of products containing asbestos was widespread across numerous industries in the United States. Between the 1930s and the 1970s — when the use of asbestos was restricted in the U.S. — hundreds of thousands of workers and ordinary citizens were exposed to asbestos, putting them at risk of developing mesothelioma cancer, asbestosis, lung cancer, or other diseases linked to asbestos. (more…)

By |2020-10-19T16:41:35+00:00June 25th, 2020|Mesothelioma and Asbestos|Comments Off on What is the difference between mesothelioma lawsuits and asbestos trust fund claims?

Hundreds of lawsuits filed by Zantac, ranitidine users diagnosed with cancer

In 2019, the heartburn medications Zantac and ranitidine were recalled and studies showed that they were contaminated with a chemical that could increase the cancer risk of patients who were treated with these drugs. Consumers who used Zantac or ranitidine and were diagnosed with cancer may qualify to file a lawsuit and receive compensation for their injuries. (more…)

By |2020-10-19T16:40:50+00:00June 6th, 2020|Zantac & Ranitidine|Comments Off on Hundreds of lawsuits filed by Zantac, ranitidine users diagnosed with cancer

3M officials deny servicemembers deserved to know about Combat Arms Ear Plugs risks

Officials with 3M have said that U.S. soldiers who used the company’s Combat Arms Ear Plugs did not need to know about potential safety issues with the products. These statements were made in a deposition that was recently unseal as part of the thousands of lawsuits against 3M over safety issues involving the Combat Arms earplugs. (more…)

By |2020-10-19T16:40:39+00:00May 21st, 2020|3M Combat Arms Earplugs|Comments Off on 3M officials deny servicemembers deserved to know about Combat Arms Ear Plugs risks

Class action lawsuit alleges Eisai, Arena hid cancer risk of Belviq weight loss drug

Eisai Inc. and Arena Pharmaceuticals — the makers of the drugs Belviq and Belviq XR (lorcaserin) — face a class action lawsuit alleging that the weight loss drugs increase the cancer risk of patients who used them. The lawsuits, filed in March at the U.S. District Court in White Plains, New York, seeks class action status on behalf of patients who used Belviq for weight loss and were diagnosed with cancer. (more…)

By |2020-10-22T14:54:42+00:00April 28th, 2020|Belviq|Comments Off on Class action lawsuit alleges Eisai, Arena hid cancer risk of Belviq weight loss drug

FDA orders recall of Belviq weight loss drug after study finds increased cancer risk

The U.S. Food and Drug Administration has requested that Eisai Inc., the manufacturer of the weight loss drug Belviq, recall the drug after a study found that it could increase the risk of developing pancreatic cancer, colorectal cancer, or lung cancer. (more…)

By |2020-10-19T16:40:08+00:00April 27th, 2020|Belviq|Comments Off on FDA orders recall of Belviq weight loss drug after study finds increased cancer risk